Ian White

Founder and CEO

Dr. White is considered a leading expert in the field of aging and regenerative medicine with 20 years’ experience working with stem cells, regenerative cells and tissue regeneration. Dr. White received degrees Liverpool University prior to being recruited to Harvard University to work with hematopoietic stem cells (HSC) and immune cell biology under the mentorship of the world-renowned Dr. Laurie Glimcher, where he co-authored several high impact peer-reviewed scientific manuscripts on the subject. Dr. White went on to receive his Ph.D. from the Ansary Stem Cell Institute, Division of Regenerative Medicine at Cornell University under the guidance of Dr. Shahin Rafii. During this time Dr. White developed an in vitro method for culture expanding autologous stem cells in an artificial vascular niche for the treatment of cancer patients who have undergone bone marrow ablation following chemo- or radio-therapy. This technology has since gone on to be commercialized by Cornell University and has been described in several co-authored manuscripts and research grants awarded by the NIH.
Since his Ph.D. Dr. White spent some time in the embryonic stem cell (ESC) laboratory of Dr. Stephen Dalton, who’s pioneering work led to the inclusion of c-myc as one of the 4 factors used by Nobel award winning Dr. Shinya Yamanaka in the generation of induced pluripotent stem cells (iPSCs).
Subsequently, Dr. White relocated to the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine. Dr. White published ground-breaking research in the field of regenerative medicine alongside Dr. Joshua Hare, including a book chapter on the use of Mesenchymal Signaling Cells (MSCs) in Cardiology. In 2015 Dr. White’s work on the regeneration of the heart was featured on the cover of Circulation Research, one of the top peer-reviewed journals for cardiovascular medicine in the world. In 2016 Dr.

Talks About
#biology

Preferred Locations
#NorthAmerica